N

Navamedic ASA
OSE:NAVA

Watchlist Manager
Navamedic ASA
OSE:NAVA
Watchlist
Price: 25.2 NOK -0.79% Market Closed
Market Cap: 604.3m NOK

Intrinsic Value

The intrinsic value of one NAVA stock under the Base Case scenario is 40.49 NOK. Compared to the current market price of 25.2 NOK, Navamedic ASA is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NAVA Intrinsic Value
40.49 NOK
Undervaluation 38%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
Navamedic ASA

What is Valuation History?
Ask AI Assistant
What other research platforms think about NAVA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NAVA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Navamedic ASA.

Explain Valuation
Compare NAVA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NAVA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Navamedic ASA

Current Assets 218.3m
Cash & Short-Term Investments 46.4m
Receivables 73.4m
Other Current Assets 98.6m
Non-Current Assets 267.2m
PP&E 7m
Intangibles 253.6m
Other Non-Current Assets 6.6m
Current Liabilities 167.6m
Accounts Payable 80.4m
Other Current Liabilities 87.2m
Non-Current Liabilities 101.4m
Long-Term Debt 71.3m
Other Non-Current Liabilities 30.1m
Efficiency

Free Cash Flow Analysis
Navamedic ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Navamedic ASA

Revenue
523.6m NOK
Cost of Revenue
-328.6m NOK
Gross Profit
194.9m NOK
Operating Expenses
-173.8m NOK
Operating Income
21.1m NOK
Other Expenses
-54.3m NOK
Net Income
-33.2m NOK
Fundamental Scores

NAVA Profitability Score
Profitability Due Diligence

Navamedic ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Gross Margin
42/100
Profitability
Score

Navamedic ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

NAVA Solvency Score
Solvency Due Diligence

Navamedic ASA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
47/100
Solvency
Score

Navamedic ASA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NAVA Price Targets Summary
Navamedic ASA

Wall Street analysts forecast NAVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NAVA is 36.72 NOK with a low forecast of 36.36 NOK and a high forecast of 37.8 NOK.

Lowest
Price Target
36.36 NOK
44% Upside
Average
Price Target
36.72 NOK
46% Upside
Highest
Price Target
37.8 NOK
50% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NAVA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one NAVA stock?

The intrinsic value of one NAVA stock under the Base Case scenario is 40.49 NOK.

Is NAVA stock undervalued or overvalued?

Compared to the current market price of 25.2 NOK, Navamedic ASA is Undervalued by 38%.

Back to Top